The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design

Nature
Rupert J RussellJohn J Skehel

Abstract

The worldwide spread of H5N1 avian influenza has raised concerns that this virus might acquire the ability to pass readily among humans and cause a pandemic. Two anti-influenza drugs currently being used to treat infected patients are oseltamivir (Tamiflu) and zanamivir (Relenza), both of which target the neuraminidase enzyme of the virus. Reports of the emergence of drug resistance make the development of new anti-influenza molecules a priority. Neuraminidases from influenza type A viruses form two genetically distinct groups: group-1 contains the N1 neuraminidase of the H5N1 avian virus and group-2 contains the N2 and N9 enzymes used for the structure-based design of current drugs. Here we show by X-ray crystallography that these two groups are structurally distinct. Group-1 neuraminidases contain a cavity adjacent to their active sites that closes on ligand binding. Our analysis suggests that it may be possible to exploit the size and location of the group-1 cavity to develop new anti-influenza drugs.

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Sep 15, 1993·Structure·W P BurmeisterR W Ruigrok
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Feb 15, 2001·The Journal of Infectious Diseases·L V GubarevaF G Hayden
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y HaD C Wiley
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Feb 15, 2005·The Journal of Antimicrobial Chemotherapy·Penelope WardRegina Dutkowski
Sep 28, 2005·Science·P C CrawfordRuben O Donis
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Hui-Ling YenElena A Govorkova
Oct 18, 2005·Nature·Q Mai LeYoshihiro Kawaoka
Oct 28, 2005·Antimicrobial Agents and Chemotherapy·Vasiliy P MishinLarisa V Gubareva
Dec 2, 2005·Emerging Infectious Diseases·UNKNOWN World Health Organization Global Influenza Program Surveillance Network
Dec 24, 2005·The New England Journal of Medicine·Menno D de JongJeremy Farrar
Feb 24, 2006·Emerging Infectious Diseases·Robert G WebsterYi Guan

❮ Previous
Next ❯

Citations

Jun 21, 2011·Medical Microbiology and Immunology·Katja BauerMichaela Schmidtke
Nov 13, 2008·Amino Acids·Maturos MalaisreeSupot Hannongbua
Sep 21, 2010·Journal of Molecular Modeling·Michal Raab, Igor Tvaroška
Jan 27, 2012·Journal of Molecular Modeling·Ye WangXuexun Fang
May 21, 2013·Trends in Microbiology·Kanta Subbarao, Yumiko Matsuoka
Mar 4, 2014·Trends in Microbiology·Ying WuGeorge F Gao
Nov 3, 2010·Journal of Chemical Information and Modeling·Sudipto MukherjeeRobert C Rizzo
Apr 28, 2011·Journal of Chemical Information and Modeling·Yan LiRenxiao Wang
Sep 14, 2011·Journal of Chemical Information and Modeling·Ian R CraigKatrin Spiegel
Sep 18, 2012·Journal of Chemical Information and Modeling·Ariela Vergara-JaqueChristophe Chipot
Sep 25, 2012·Journal of Chemical Information and Modeling·Lin LiTingjun Hou
Sep 29, 2011·Journal of the American Chemical Society·Jiun-Jie ShieChi-Huey Wong
May 23, 2012·Journal of Medicinal Chemistry·Kalyan Das
Sep 12, 2012·Journal of Medicinal Chemistry·Kung-Cheng LiuChi-Huey Wong
Sep 29, 2012·Journal of Medicinal Chemistry·Beenu BhattMark von Itzstein
Nov 18, 2010·Nature Communications·Santosh RudrawarMark von Itzstein
Jul 14, 2011·Nature Communications·Rommie E AmaroRobin M Bush
Dec 2, 2006·Nature Reviews. Drug Discovery·Erik De Clercq
Dec 1, 2007·Nature Reviews. Drug Discovery·Mark von Itzstein
Jul 19, 2013·Nature Reviews. Genetics·Michael J Harms, Joseph W Thornton
Apr 13, 2010·Nature Structural & Molecular Biology·Kalyan DasEddy Arnold
Sep 21, 2010·Nature Structural & Molecular Biology·Qing LiGeorge F Gao
Oct 30, 2009·Physical Chemistry Chemical Physics : PCCP·Zhiwei YangLijun Zhou
Sep 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Qing LiGeorge F Gao
Sep 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Xueyong ZhuIan A Wilson
Oct 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Adolfo García-Sastre
Nov 15, 2012·The Journal of Biological Chemistry·Diogo V da SilvaRobert Daniels
Jun 12, 2010·The Journal of Biological Chemistry·Steven J Gamblin, John J Skehel
Jul 9, 2009·Journal of Biomolecular Structure & Dynamics·Chien-Yu ChenCalvin Yu-Chian Chen
Jan 13, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Iain StephensonMaria Zambon
Jul 10, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Arnold S Monto
Dec 4, 2012·Bioinformatics·Lane Votapka, Rommie E Amaro
Nov 4, 2008·Current Opinion in Infectious Diseases·Angie LackenbyJane Democratis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.